ANI Pharmaceuticals
Presence
ANI Pharmaceuticals is one of the...
ANI Pharmaceuticals is a company listed under the stock ticker ANIP (US).
Executives
View the org chart displaying its 17 main executives
Most searched biographies at ANI Pharmaceuticals
- Nikhil Lalwani, Director, President and Chief Executive Officer
- David Nash, Director
- Antonio Pera, Director
Popular executive movements at ANI Pharmaceuticals
- Matthew Leonard has joined the company as Director (posted on August 24 2023).
Create your alert
to follow the executive moves at ANI Pharmaceuticals.
Biotechnology
ANI Pharmaceuticals has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
- WindRose Health Investors has announced the acquisition of SubjectWell (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by ANI Pharmaceuticals
- ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Clorazepate Dipotassium Tablets USP
- ANI Pharmaceuticals Adopts Veeva Commercial Cloud to Better Support Rare Disease Patients
- ANI Pharmaceuticals Announces Consolidation of Manufacturing Network, Capturing Operational Synergies Post Novitium Acquisition
- ANI Pharmaceuticals Announces the FDA Approval and Imminent Launch of Fludrocortisone Acetate Tablets USP
- ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences
- ANI Pharmaceuticals Reports First Quarter 2022 Results; Provides Purified Cortrophin® Gel Net Revenue Guidance and Full-Year 2022 Total Company Net Revenue Guidance of $295 Million to $315 Million
- ANI Pharmaceuticals to Discuss First Quarter 2022 Financial Results on May 10, 2022
- ANI Pharmaceuticals Announces the Launch of Misoprostol Tablets
- ANI Pharmaceuticals Appoints Experienced Commercial Leader, Renee P. Tannenbaum, Pharm.D., MBA, to Board of Directors
- ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; Strong Foundation in Place to Drive Sustainable Growth
- View more press releases Close
Social media about ANI Pharmaceuticals
- ANI Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- ANI Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Nikhil Lalwani 
Call ANI Pharmaceuticals at +1 218...
